statistiche ricercatore

Continente	#
NA - Nord America	1.081
EU - Europa	990
AS - Asia	658
SA - Sud America	112
AF - Africa	31
OC - Oceania	5
Continente sconosciuto - Info sul continente non disponibili	3
Totale	2.880

Nazione	#
US - Stati Uniti d'America	1.050
DE - Germania	387
SG - Singapore	240
CN - Cina	223
SE - Svezia	165
PL - Polonia	107
BR - Brasile	95
IT - Italia	83
UA - Ucraina	60
FR - Francia	53
VN - Vietnam	37
GB - Regno Unito	34
IN - India	29
IE - Irlanda	26
HK - Hong Kong	22
ID - Indonesia	19
JP - Giappone	19
FI - Finlandia	17
RU - Federazione Russa	17
CA - Canada	16
BD - Bangladesh	11
IQ - Iraq	10
ZA - Sudafrica	9
KR - Corea	8
MX - Messico	8
NL - Olanda	8
CI - Costa d'Avorio	7
CO - Colombia	7
GR - Grecia	6
TR - Turchia	6
AU - Australia	5
ES - Italia	5
IR - Iran	5
PK - Pakistan	5
CZ - Repubblica Ceca	4
LT - Lituania	4
UZ - Uzbekistan	4
AR - Argentina	3
BG - Bulgaria	3
JO - Giordania	3
SA - Arabia Saudita	3
TN - Tunisia	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
CR - Costa Rica	2
EG - Egitto	2
HU - Ungheria	2
JM - Giamaica	2
KE - Kenya	2
MA - Marocco	2
MY - Malesia	2
PH - Filippine	2
TH - Thailandia	2
TT - Trinidad e Tobago	2
XK - ???statistics.table.value.countryCode.XK???	2
A1 - Anonimo	1
AL - Albania	1
AO - Angola	1
AZ - Azerbaigian	1
BE - Belgio	1
BO - Bolivia	1
BW - Botswana	1
CL - Cile	1
DZ - Algeria	1
EC - Ecuador	1
GH - Ghana	1
HN - Honduras	1
HR - Croazia	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LV - Lettonia	1
MZ - Mozambico	1
NO - Norvegia	1
NP - Nepal	1
OM - Oman	1
PY - Paraguay	1
RO - Romania	1
SI - Slovenia	1
SN - Senegal	1
Totale	2.880

Nome	#
Fanconi anemia gene variants in therapy-related myeloid neoplasms	322
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies	269
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES	241
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome.	239
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES	236
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA	214
Why methylation is not a marker predictive of response to hypomethylating agents	194
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes	190
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms	186
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.	183
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases	175
Clonal evolution in therapy-related neoplasms	173
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes	150
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes	131
Totale	2.903

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	112	0	0	0	0	0	0	0	0	0	34	61	17
2021/2022	176	14	16	1	5	11	11	3	43	10	20	21	21
2022/2023	392	65	61	26	77	17	35	15	40	29	0	20	7
2023/2024	170	10	37	5	10	4	51	1	10	5	2	19	16
2024/2025	255	6	5	30	7	41	4	23	9	26	21	51	32
2025/2026	700	96	13	35	63	122	50	139	32	104	46	0	0
Totale													2.903

IRIS UniCatt